Fibrinogen Human Completed Phase 4 Trials for Cardiovascular Surgery / Hemorrhage / Hemostasis Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00440401TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)